Werewolf Therapeutics, Inc. financial data

Symbol
HOWL on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Talcott Avenue, 2 Nd Floor, Watertown, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 845 % +8.91%
Debt-to-equity 53 % +3.68%
Return On Equity -58.8 % -87.1%
Return On Assets -38.5 % -84.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 44.6M shares +23.1%
Common Stock, Shares, Outstanding 43.7M shares +22.6%
Entity Public Float 67.4M USD +13.6%
Common Stock, Value, Issued 4K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 43.7M shares +22.6%
Weighted Average Number of Shares Outstanding, Diluted 43.7M shares +22.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 50.4M USD +4.94%
General and Administrative Expense 19.2M USD +4.22%
Operating Income (Loss) -66.2M USD -62.6%
Nonoperating Income (Expense) 4.09M USD +19.4%
Net Income (Loss) Attributable to Parent -62.1M USD -66.6%
Earnings Per Share, Basic -1.51 USD/shares -39.8%
Earnings Per Share, Diluted -1.54 USD/shares -42.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 123M USD -5.56%
Assets, Current 126M USD -9.64%
Property, Plant and Equipment, Net 6.77M USD -18.9%
Operating Lease, Right-of-Use Asset 6.18M USD -14.8%
Other Assets, Noncurrent 42K USD -91.9%
Assets 140M USD -20.6%
Accounts Payable, Current 1.24M USD -10.5%
Employee-related Liabilities, Current 2.8M USD +5.03%
Accrued Liabilities, Current 9.9M USD +24.3%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 12.5M USD -13.7%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 9.84M USD -13.3%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 50.7M USD -20.8%
Retained Earnings (Accumulated Deficit) -394M USD -18.7%
Stockholders' Equity Attributable to Parent 89.4M USD -20.5%
Liabilities and Equity 140M USD -20.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -15.3M USD -54.5%
Net Cash Provided by (Used in) Financing Activities 20.3M USD -58.3%
Net Cash Provided by (Used in) Investing Activities -111K USD +33.9%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 43.7M shares +22.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 4.85M USD -87.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 124M USD -18%
Interest Paid, Excluding Capitalized Interest, Operating Activities 910K USD
Deferred Tax Assets, Valuation Allowance 47.1M USD +10.9%
Deferred Tax Assets, Gross 50.3M USD +8.77%
Operating Lease, Liability 12.6M USD -14.2%
Depreciation 464K USD +9.18%
Payments to Acquire Property, Plant, and Equipment 111K USD -33.9%
Lessee, Operating Lease, Liability, to be Paid 16M USD -16.4%
Property, Plant and Equipment, Gross 11.1M USD +7.06%
Operating Lease, Liability, Current 1.32M USD -17.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.34M USD -6.71%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.51M USD -20%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.37M USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.4M USD +2.82%
Deferred Tax Assets, Operating Loss Carryforwards 23.9M USD -9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.47M USD +2.83%
Additional Paid in Capital 484M USD +8.79%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 3.2M USD -15.6%
Share-based Payment Arrangement, Expense 8.79M USD +8.84%
Interest Expense 1M USD +483%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%